Antimicrobial Therapeutic Drug Monitoring Workshop

Strong associations exist between drug exposure and patient outcome for many antimicrobials. Therapeutic drug monitoring (TDM) is an obvious method to apply to ensure more patients achieve effective drug concentrations and should be considered standard-of-care for most antimicrobials. However, there remains uncertainty and inconsistency with practice for which patients would most benefit from TDM, which antimicrobial concentration targets should be used and what feasible methods could be applied to effectively change doses. In this workshop, we will address these issues as they relate to antibacterials, antifungals and antimycobacterials. We will also present new technological advances that improve the feasibility and accuracy of antimicrobial TDM and specific considerations for key settings including paediatrics and outpatients (and critically ill patients of course!) as well as the place of dosing software. Please join us and hear from leading practitioners and scientists in this area!

Antimicrobial Therapeutic Drug Monitoring Workshop

Wednesday, 11 November 2020, Proposed Virtual Event

Preliminary Workshop Programme
Time Topic Speaker
0845-0900 Log in for the webinar -
Session 1: Dose Optimisation and PK PD                                                                                                                                                            Chair Prof Jason Roberts
0900-0905 Welcome Prof Jason Roberts (Brisbane)
0905-0925 The need for antimicrobial dose optimisation Prof Jason Roberts (Brisbane)
0925-0945 Different approaches to antimicrobial dose optimisation Mr Paul Williams (Sunshine Coast)
0945-1005 Antibacterial pharmacokinetic-pharmacodynamic targets Dr Kathryn Daveson (Canberra)
1005-1025 Antifungal pharmacokinetic-pharmacodynamic targets Dr Hafiz Abdul-Aziz (Brisbane)
1025-1045 Antimycobacterial pharmacokinetic-pharmacodynamic targets Dr Andrew Burke (Brisbane)
1045-1105 Morning Tea
Session 2: Therapeutic Drug Monitoring Concepts Chair Dr Suzanne Parker (Brisbane)
1105-1125 Principles of therapeutic drug monitoring (TDM) A/Prof Darren Roberts (Sydney)
1125-1145 Outcome and cost-effectiveness data supporting antimicrobial TDM Dr Gloria Wong (Brisbane)
1145-1205 Considerations for TDM in paediatrics Dr Amanda Gwee (Melbourne)
1205-1225 Antimicrobial susceptibility testing considerations for TDM Prof John Turnidge (Adelaide)
1225-1245 Study design considerations to quantify the clinical value of TDM Prof Jan-Willem Alffenaar (Sydney)
1245-1345 Lunch
Session 3: Dosing Software Chair Dr Andrew Burke (Brisbane)
1345-1405 Use of TDM in the outpatient setting Dr Kate McCarthy (Brisbane)
1405-1425 Technological advances to revolutionise TDM: Sampling and Bioanalytics Dr Suzanne Parker (Brisbane)
1425-1445 Technological advances to revolutionise TDM: Dosing software Mr Gene Chai (Brisbane)

IDS-ODS Dosing Software

Dr Andras Farkas (New York)
1515-1545 Afternoon tea
Session 4: Dosing Software Practical Applications Chair Prof Jason Roberts (Brisbane)
1545-1630 IDS-ODS case studies: vancomycin and meropenem Mr Paul Williams and Mr Gene Chai (Brisbane)
1630-1640 Close Prof Jason Roberts
1640-1800 Dinner break  
Session 5: European Perspectives Chair Dr Claire Roger (Nîmes)
AEST CET Topic Speaker
1800-1805 0900-0905 Welcome from Nîmes Dr Claire Roger
1805-1825 0905-0925 European Guidelines for antimicrobial TDM Dr Jan De Waele
1830-1850 0930-0950 Antifungal penetration into different body sites TBC
1855-1915 0955-1015 Dosing software for optimising therapy TBC
1920-1940 1020-1040 Dosing challenges in obese patients TBC
1945-2005 1045-1105 Vancomycin use in Europe TBC
2010-2030 1110-1130 TDM of linezolid and daptomycin Dr Sonia Luque
2030-2040 1130-1140 Close Dr Claire Roger

Thank you to our sponsors.



Therapeutic Drug Monitoring Workshop

Wed 11 Nov 2020 8:30am8:30pm


Zoom details will be provided following registration.

This event is co-organised by CRE REDUCE, UQ and CHU Nîmes.




Luminita Vlad
07 3346 5045